Inventor · disambiguated record
Robert L. Vitti
Also filed as: VITTI ROBERT · VITTI ROBERT L
5 granted patents·8 pending applications·8 citations·filing 2011–2025
70Inventor score
Top patents by PatentIndex Score
13 records- 0188US10973879B2Use of a VEGF antagonist to treat angiogenic eye disordersREGENERON PHARMA·Filed 2018·Granted Apr 13, 2021·5 cites·21 claims
- 0276US10968278B2Compositions comprising IL6R antibodies for the treatment of uveitis and macular edema and methods of using sameSANOFI BIOTECHNOLOGY·Filed 2016·Granted Apr 6, 2021·3 cites·24 claims
- 0366US12280093B2Use of a VEGF receptor-based fusion protein antagonist to treat nonproliferative diabetic retinopathyREGENERON PHARMA·Filed 2021·Granted Apr 22, 2025·0 cites·33 claims
- 0466US11071780B2Methods and formulations for treating vascular eye diseases using aflibercept and nesvacumabREGENERON PHARMA·Filed 2018·Granted Jul 27, 2021·0 cites·9 claims
- 0561US2025268983A1Use of a VEGF Antagonist to Treat Angiogenic Eye DisordersREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0657US2025025531A1Extended, High Dose VEGF Antagonist Regimens for Treatment of Angiogenic Eye DisordersREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0755US2024024420A1Extended, High Dose VEGF Antagonist Regimens for Treatment of Angiogenic Eye DisordersREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0853US2023295266A1Extended, High Dose VEGF Antagonist Regimens for Treatment of Angiogenic Eye DisordersREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0952US2023302085A1Extended, High Dose VEGF Antagonist Regimens for Treatment of Angiogenic Eye DisordersREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 1050US2021301027A1Compositions comprising il6r antibodies for the treatment of uveitis and macular edema and methods of using sameSANOFI BIOTECHNOLOGY·Filed 2021·Application pending·0 cites
- 1149US2017080086A1Methods and formulations for treating vascular eye diseasesREGENERON PHARMA·Filed 2016·Application pending·0 cites
- 1246US2016144025A1Methods and formulations for treating vascular eye diseasesREGENERON PHARMA·Filed 2015·Application pending·0 cites
- 1335US8805706B2Systems and methods for managing insurance account documentsCUNNINGHAM KATHLEEN ANNE·Filed 2011·Granted Aug 12, 2014·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Robert L. Vitti files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →